| Sign In to gain access to subscriptions and/or personal tools. |
Factor V Leiden and Its Effect on Children With Cardiac PathologyDepartment of Cardiology, Childrens Hospital, 300 Longwood Avenue, Boston, MA 02115Jean.Connor{at}cardio.chboston.org Factor V Leiden thrombophilia, formed by a genetic mutation, slows the bodys anticoagulation response to clot formation. First described in 1994, factor V Leiden mutation has been identified as a contributing risk factor for venous thromboembolism. Although venous thromboembolism is considered rare in the pediatric population, Factor V Leiden has implications for certain at-risk pediatric patients.
Key Words: Factor V Leiden children with congenital heart disease genetic screening pediatric risk factors pediatrics prevalence venous thrombosis
Journal of Pediatric Oncology Nursing, Vol. 22, No. 3,
176-181 (2005) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||